Photochemotherapy for pustular psoriasis (von Zumbusch)

Area of Science:

• Dermatology
• Photobiology
• Immunology

Background:

• Generalized pustular psoriasis (von Zumbusch) is a severe dermatosis characterized by widespread pustules and systemic inflammation.
• Traditional systemic therapies can have significant side effects and variable efficacy.
• Photochemotherapy, specifically psoralen plus ultraviolet A (PUVA), is explored as an alternative treatment modality.

Purpose of the Study:

• To evaluate the efficacy and safety of photochemotherapy (PUVA) for treating generalized pustular psoriasis (von Zumbusch).

Main Methods:

• Eight patients diagnosed with generalized pustular psoriasis received photochemotherapy (PUVA) using oral methoxsalen and UV-A radiation.
• Treatment protocols were adjusted based on prior therapies (systemic vs. topical).
• Patients were monitored for lesion clearance, systemic symptom resolution, and long-term remission during maintenance therapy.

Main Results:

• Complete clearing of both skin lesions and systemic symptoms was observed in all 8 patients.
• Patients previously treated with systemic therapies required higher UV-A doses compared to those treated with topical therapy alone.
• Seven out of eight patients achieved complete remission with maintenance therapy over an observation period up to 1.5 years.
• Adverse effects from pre-PUVA systemic treatments resolved during the maintenance phase.

Conclusions:

• Photochemotherapy (PUVA) is a highly effective treatment for generalized pustular psoriasis, achieving complete clinical and systemic remission.
• Maintenance therapy can sustain remission for extended periods.
• PUVA offers a viable therapeutic option with manageable side effects, particularly for patients unresponsive or intolerant to other treatments.